Do Fanconi anemia genes control cell response to cross-linking agents by modulating cytochrome P-450 reductase activity?

This publication has 39 references indexed in Scilit:

• The role of reductive enzymes in cancer cell resistance to mitomycin C
  Drug Resistance Updates, 2000
• Overexpression of thioredoxin in Fanconi anemia fibroblasts prevents the cytotoxic and DNA damaging effect of mitomycin C and diepoxybutane
  FEBS Letters, 1998
• The role of oxygen metabolism for the pathological phenotype of Fanconi anemia
  Human Genetics, 1997
• Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA
  Nature Genetics, 1996
• Reductase Enzyme Expression Across the National Cancer Institute Tumor Cell Line Panel: Correlation With Sensitivity to Mitomycin C and EO9
  JNCI Journal of the National Cancer Institute, 1996
• In vivo accumulation of 8-hydroxy-2'-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families
  Carcinogenesis: Integrative Cancer Research, 1995
• Regulation of the transcription factors NF-κB and AP-1 by redox changes
  Chemico-Biological Interactions, 1994
• Relevance of DT‐diaphorase activity to mitomycin C (MMC) efficacy on human cancer cells: Differences in in vitro and in vivo systems
  International Journal of Cancer, 1993
• Redox Regulation of Fos and Jun DNA-Binding Activity in Vitro
  Science, 1990
• Suppression of cylotoxic effect of mitomycin-C by superoxide dismutase in Fanconi's anemia and dyskeratosis congenita fibroblasts
  Carcinogenesis: Integrative Cancer Research, 1982